The FDA-approved Spiration Valve System (SVS) is an innovative endobronchial technology that offers patients with severe emphysema a customized, minimally invasive treatment option for lung volume reduction with a favorable risk-benefit profile. In clinical trials, patients treated with the SVS experienced improved breathing, lung function and quality of life[1].
1 Criner GJ, et al. Am J Respir Crit Care Med. 2019.
https://www.atsjournals.org/doi/full/10.1164/rccm.201902-0383OC